Cardiovascular adverse events of ibrutinib

被引：14
|
作者：
Ahn, Inhye E. [1 ]
机构：
[1] NHLBI, Bldg 10, Bethesda, MD 20892 USA
来源：
BLOOD | 2019年 / 134卷 / 22期
关键词：
D O I：
10.1182/blood.2019002805
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Dickerson et al report on the increased incidence and worsening severity of hypertension and its association with cardiovascular outcomes in 562 patients treated with ibrutinib for B-cell malignancies.(1)
引用
收藏
页码：1881 / 1882
页数：2
相关论文
共 50 条
  • [21] Varenicline and cardiovascular adverse events: a perspective review
    Chelladurai, Yohalakshmi
    Singh, Sonal
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2014, 5 (04) : 167 - 172
  • [22] Gastrointestinal and cardiovascular adverse events associated with NSAIDs
    Domper Arnal, Maria-Jose
    Hijos-Mallada, Gonzalo
    Lanas, Angel
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (03) : 373 - 384
  • [23] Prediabetes and the Incidence of Major Adverse Cardiovascular Events
    Booth, Gillian L.
    Rezai, Mohammad R.
    Atzema, Clare
    Austin, Peter C.
    Bhatia, Sacha
    Bierman, Arlene S.
    Clemens, Kristin K.
    Johnston, Sharon
    Ko, Dennis T.
    Lee, Douglas S.
    Tu, Karen
    Tu, Jack V.
    DIABETES, 2017, 66 : A81 - A82
  • [24] Adverse Cardiovascular Events Associated With Kopi Jantan
    Othman, Mohd Khairi
    Yusof, Zurkurnai
    Rossli, Nur Imani Mohd
    Fauzi, Mohd Hafizazham Mohd
    Isa, W. Yus Haniff
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [25] Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events
    Douros, Antonios
    Yu, Oriana Hoi Yun
    Yin, Hui
    Filion, Kristian B.
    Azoulay, Laurent
    Suissa, Samy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 245 - 245
  • [26] Adverse cardiovascular events associated with the use of Viagra
    Azarbal, B
    Mirocha, J
    Shah, PK
    Cercek, B
    Kaul, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 553A - 554A
  • [27] Cardiovascular adverse events with contemporary cancer therapies
    Reactions Weekly, 2020, 1793 (1) : 8 - 8
  • [28] Predicting adverse cardiovascular events in bupropion overdose
    Simpson, Michael
    Campleman, Sharan
    Brent, Jeffrey
    Wax, Paul
    Manini, Alex
    CLINICAL TOXICOLOGY, 2023, 61 : 106 - 106
  • [29] Review times and adverse events for cardiovascular devices
    Stern, Ariel Dora
    Kramer, Daniel B.
    Ouellet, Melissa
    Kesselheim, Aaron S.
    NATURE BIOMEDICAL ENGINEERING, 2017, 1 (01):
  • [30] Aspirin for the Primary Prevention of Adverse Cardiovascular Events
    Estes, Krista
    Thomure, Jessica
    CRITICAL CARE NURSING QUARTERLY, 2008, 31 (04) : 324 - 339
12345